Browsing Tag
ASX
164 posts
Neuren Pharmaceuticals advances NNZ-2591 for Phelan-McDermid syndrome to Phase 3 clinical trial
Neuren Pharmaceuticals has secured approval from the United States Food and Drug Administration (FDA) to progress into the…
Chimeric Therapeutics announces breakthrough AML response with CHM CORE-NK in Phase 1B trial
Chimeric Therapeutics has reported a significant milestone in its ongoing clinical trials, wherein a patient diagnosed with Acute…
Immuron Limited reveals key findings from NMRC study, eyes future collaboration with U.S. DoD
Immuron Limited has announced the results of a Campylobacter human infection model study conducted by the U.S. Naval…
Realty ONE Group partners with RMA Global to empower 20,000 agents
RMA Global Limited (ASX: RMY) has unveiled an exciting new partnership with Realty ONE Group, marking a significant…
Noxopharm bags new funding to fuel game-changing cancer treatments
Noxopharm Limited, an Australian biotech powerhouse, has successfully raised A$2.1 million in funding through the issuance of convertible…
Step One founder Greg Taylor sells stake amid investor surge
Step One Clothing Limited, the leading online direct-to-consumer innerwear brand, recently announced a significant development involving its founder…
Pharma breakthrough! BioIntelect to revolutionise trials using Opyl’s cutting-edge tech
In a landmark collaboration, Opyl Limited announced a new six-month agreement with BioIntelect, a renowned Clinical Research Organisation…
Huge copper and gold finds at Bluebird: Tennant Minerals stock set for a rebound?
Tennant Minerals Limited (ASX: TMS) has announced a series of significant high-grade copper and gold intersections from its…
Panther Metals completes A$2.2m capital raise to fund Laverton Gold Project drilling campaign
Panther Metals Ltd has successfully closed an A$2.22 million capital raising, paving the way for a significant drilling…
Actinogen Medical makes bold A$11.1m move to boost Alzheimer’s drug trial
Actinogen Medical has raised 11.1 million AUD in a significant capital raise led by its CEO, Dr. Steven…